Page last updated: 2024-09-05

n-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide and Breast Cancer

n-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Choi, KC; Go, RE; Kim, CW; Lee, HK; Lee, SM1

Other Studies

1 other study(ies) available for n-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide and Breast Cancer

ArticleYear
Fenhexamid induces cancer growth and survival via estrogen receptor-dependent and PI3K-dependent pathways in breast cancer models.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2021, Volume: 149

    Topics: Amides; bcl-2-Associated X Protein; Breast Neoplasms; Cell Cycle; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-bcl-2; Receptors, Estrogen

2021